Immunotherapy
News and reporting on cancer immunotherapy.
I-Mab Begins Study of Uliledlimab Plus Tecentriq in Advanced Solid Tumors
The firm will evaluate the combination's efficacy and potential biomarkers of response in patients with ovarian cancer, head and neck cancer, NSCLC, TNBC, and other cancers.
Sequencing-Based MRD Detection in Bone Marrow May Predict ALL Relapse After CAR T-Cell Therapy
Researchers looked at relapse-related markers over time in pediatric and young adult acute lymphoblastic leukemia patients after CAR T-cell treatment.
OncoOne, GenScript ProBio Enter Agreement to Develop Monoclonal Antibodies Targeting oxMIF
With this partnership, OncoOne said it expects to have its first two oxMIF candidates enter Phase I clinical trials in 2023.
OSE Immunotherapeutics Randomizes First Patient to Phase II Trial of Vaccine in Metastatic NSCLC
The trial is evaluating its neo-epitope-based vaccine Tedopi in combination with nivolumab or chemotherapy, as compared to chemotherapy alone.
Imugene to Begin Phase II Trial of B-Cell Immunotherapy in HER2-Postive Gastric Cancer
The trial will evaluate Imugene's HER-Vaxx plus Merck KGaA and Pfizer's Bavencio and chemo in patients with HER2-positive gastric cancers.